Silke Peter
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antifungal resistance and susceptibility
Papers in
-
- Antibiotic Resistance in Bacteria 49
-
- Infection Control in Healthcare 6
- SARS-CoV-2 and COVID-19 Research 5
- Antimicrobial Resistance in Staphylococcus 4
- Clostridium difficile and Clostridium perfringens research 3
- Co-authors
- Matthias Willmann (30 shared papers)Ingo B. Autenrieth (23 shared papers)Matthias Marschal (15 shared papers)Philipp Oberhettinger (12 shared papers)Jan Liese (13 shared papers)Wichard Vogel (12 shared papers)Michael E. J. Buhl (4 shared papers)Daniela Dörfel (7 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (9 papers)Antimicrobial Agents and Chemotherapy (8 papers)Clinical Microbiology and Infection (6 papers)Journal of Clinical Microbiology (6 papers)Frontiers in Microbiology (4 papers)
- Partner nations
- GermanyNetherlandsSwitzerland
In The Last Decade
Silke Peter
95 papers receiving 4.5k citations
Silke Peter's Hit Papers
Peers
Comparison fields: 5 of 140
- Molecular Medicine 955
- Infectious Diseases 1.4k
- Clinical Biochemistry 323
- Applied Microbiology and Biotechnology 157
- Health Informatics 87
Countries citing papers authored by Silke Peter
This map shows the geographic impact of Silke Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Peter more than expected).
Fields of papers citing papers by Silke Peter
This network shows the impact of papers produced by Silke Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Peter. The network helps show where Silke Peter may publish in the future.
Co-authors
The 25 scholars most cited alongside Silke Peter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Hit paper breakdown → | 2020 | 1114 |
| 2 | Swarm Learning for decentralized and confidential clinical machine learning Hit paper breakdown → | 2021 | 646 |
| 3 | 2020 | 283 | |
| 4 | 2021 | 183 | |
| 5 | 2017 | 141 | |
| 6 | 2011 | 131 | |
| 7 | 2019 | 127 | |
| 8 | 2013 | 120 | |
| 9 | 2016 | 89 | |
| 10 | 2014 | 83 | |
| 11 | 2015 | 81 | |
| 12 | 2020 | 74 | |
| 13 | 2017 | 70 | |
| 14 | 2019 | 66 | |
| 15 | 2018 | 61 | |
| 16 | 2015 | 56 | |
| 17 | 2017 | 55 | |
| 18 | 2015 | 53 | |
| 19 | 2018 | 52 | |
| 20 | 2017 | 46 |
About Silke Peter
Silke Peter is a scholar working on Molecular Medicine, Infectious Diseases, Clinical Biochemistry, Microbiology and Applied Microbiology and Biotechnology, having authored 100 papers that have together received 4.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (49 papers), Bacterial Identification and Susceptibility Testing (11 papers), Gut microbiota and health (7 papers), Infection Control in Healthcare (6 papers), Genomics and Phylogenetic Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Clostridium difficile and Clostridium perfringens research (3 papers). The work is most often cited by research in Molecular Medicine (955 citations), Infectious Diseases (1.4k citations), Clinical Biochemistry (323 citations), Applied Microbiology and Biotechnology (157 citations) and Health Informatics (87 citations). Silke Peter has collaborated with scholars based in Germany, Netherlands and Switzerland. Frequent co-authors include Matthias Willmann, Ingo B. Autenrieth, Matthias Marschal, Philipp Oberhettinger, Jan Liese, Wichard Vogel, Michael E. J. Buhl, Daniela Dörfel, Axel G. Hamprecht and Erik C. Böttger. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Clinical Microbiology and Infection, Journal of Clinical Microbiology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.